** Shares of health insurer Humana HUM.N rise 5% to $244.5 premarket
** Co forecasts 2025 adj EPS to be ~$17 vs its previous estimate of ~$16.25
** Insurers have been grappling with persistently high costs due to increased use of healthcare services across government-backed health plans
** HUM reports Q2 medical cost ratio - the percentage of premiums spent on medical care - of 89.7% in line with analysts' estimates of 89.71%, according to data compiled by LSEG
** HUM posts Q2 adj EPS of $6.27, above analysts' estimate of $5.92
** Up to last close, stock down over 8% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。